This review is a summary of a recent speaker event on future approaches to spondyloarthropathies.
The presentations were given by renowned Australian and European clinicians at a Novartis-sponsored symposium held during the 2019 Asia Pacific League of Associations for Rheumatology and Australian Rheumatology Association (APLAR-ARA) congress.
Please login below to download this issue (PDF)